Works matching IS 00071188 AND DT 2025 AND VI 182 AND IP 7


Results: 16
    1
    2
    3
    4
    5
    6
    7
    8

    Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1416, doi. 10.1111/bph.17458
    By:
    • Topouzis, Stavros;
    • Papapetropoulos, Andreas;
    • Alexander, Steve P. H.;
    • Cortese‐Krott, Miriam;
    • Kendall, Dave A.;
    • Martemyanov, Kirill;
    • Mauro, Claudio;
    • Nagercoil, Nithyanandan;
    • Panettieri, Reynold A.;
    • Patel, Hemal H.;
    • Schulz, Rainer;
    • Stefanska, Barbara;
    • Stephens, Gary J.;
    • Teixeira, Mauro M.;
    • Vergnolle, Nathalie;
    • Wang, Xin;
    • Ferdinandy, Péter
    Publication type:
    Article
    9
    10

    Guidance on the planning and reporting of experimental design and analysis.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1413, doi. 10.1111/bph.17441
    By:
    • Curtis, Michael J.;
    • Alexander, Stephen P. H.;
    • Cortese‐Krott, Miriam;
    • Kendall, David A.;
    • Martemyanov, Kirill A.;
    • Mauro, Claudio;
    • Panettieri, Reynold A.;
    • Papapetropoulos, Andreas;
    • Patel, Hemal H.;
    • Santo, Evan E.;
    • Schulz, Rainer;
    • Stefanska, Barbara;
    • Stephens, Gary J.;
    • Teixeira, Mauro M.;
    • Vergnolle, Nathalie;
    • Wang, Xin;
    • Ferdinandy, Péter
    Publication type:
    Article
    11

    Carbonic anhydrase IX inhibition as a path to treat neuroblastoma.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1610, doi. 10.1111/bph.17429
    By:
    • Petrosiute, Agne;
    • Zakšauskas, Audrius;
    • Lučiūnaitė, Asta;
    • Petrauskas, Vytautas;
    • Baranauskienė, Lina;
    • Kvietkauskaitė, Agnė;
    • Ščerbavičienė, Alvilė;
    • Tamošiūnaitė, Marta;
    • Musvicaitė, Justina;
    • Jankūnaitė, Alberta;
    • Žvinys, Gediminas;
    • Stančaitis, Laimonas;
    • Čapkauskaitė, Edita;
    • Mickevičiūtė, Aurelija;
    • Juozapaitienė, Vaida;
    • Dudutienė, Virginija;
    • Zubrienė, Asta;
    • Grincevičienė, Švitrigailė;
    • Bukelskienė, Virginija;
    • Schiöth, Helgi B.
    Publication type:
    Article
    12
    13

    Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer's disease: A preclinical study in zebrafish.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1582, doi. 10.1111/bph.17426
    By:
    • Haridevamuthu, Balasubramanian;
    • Bharti, Ankit Kumar;
    • Nayak, Santosh Pushpa Ramya Ranjan;
    • Narayanan, Dhaareeshwar;
    • Loganathan Sumathi, Dhivya;
    • Chagaleti, Bharath Kumar;
    • Saravanan, Venkatesan;
    • Rajagopal, Rajakrishnan;
    • Alfarhan, Ahmed;
    • Muthu Kumaradoss, Kathiravan;
    • Arockiaraj, Jesu
    Publication type:
    Article
    14

    Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1466, doi. 10.1111/bph.17407
    By:
    • Hasegawa, Masaya;
    • Kunisawa, Kazuo;
    • Wulaer, Bolati;
    • Kubota, Hisayoshi;
    • Kurahashi, Hitomi;
    • Sakata, Takatoshi;
    • Ando, Honomi;
    • Fujigaki, Suwako;
    • Fujigaki, Hidetsugu;
    • Yamamoto, Yasuko;
    • Nagai, Taku;
    • Saito, Kuniaki;
    • Nabeshima, Toshitaka;
    • Mouri, Akihiro
    Publication type:
    Article
    15
    16

    Issue Information.

    Published in:
    British Journal of Pharmacology, 2025, v. 182, n. 7, p. 1411, doi. 10.1111/bph.16448
    Publication type:
    Article